Document is current
Any future updates will be listed below
-
Authors
Knight, Erin M. https://orcid.org/0000-0002-5020-8905
Carluzzo, Kathleen L.
Reeve, Bryce B.
Mueller, Kristen L.
Singh, Jasvinder A.
Lin, Li
Schifferdecker, Karen E.
-
Funding
Funding for this research was provided by:
Arthritis Foundation (N/A (contract for related work))
- License Information
-
More Information
Article History
Accepted: 30 October 2024
First Online: 20 November 2024
Declarations
:
: EMK, KLC, and KES report funding provided by contracts with the Arthritis Foundation to conduct related work. EMK received a travel bursary award to attend the 2023 EULAR Congress to present this work. KLM is Vice Chair of the Board for Health Research Alliance, which is an unpaid position. JAS reports consulting fees paid by AstraZeneca, Crealta/Horizon, Medisys, Fidia, PK Med, Two labs Inc., Adept Field Solutions, Clinical Care options, Clearview healthcare partners, Putnam associates, Focus forward, Navigant consulting, Spherix, MedIQ, Jupiter Life Science, UBM LLC, Trio Health, Medscape, WebMD, and Practice Point communications; and the National Institutes of Health and the American College of Rheumatology; participation on the speaker’s bureau of Simply Speaking for which he has received honoraria; membership on the steering committee of OMERACT, from which he received support to attend meetings every 2 years; participation on the FDA Arthritis Advisory Committee, with no financial support; participation as the Co-Chair of the Veterans Affairs Rheumatology Field Advisory Committee, from which he receives no financial support; participation as editor and Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis, from which he receives no financial support; ownership of stock options in Atai life sciences, Kintara therapeutics, Intelligent Biosolutions, Acumen pharmaceutical, TPT Global Tech, Vaxart pharmaceuticals, Atyu biopharma, Adaptimmune Therapeutics, GeoVax Labs, Pieris Pharmaceuticals, Enzolytics Inc., Seres Therapeutics, Tonix Pharmaceuticals Holding Corp., and Charlotte’s Web Holdings, Inc.; and previous ownership of stock options in Amarin, Viking and Moderna pharmaceuticals.
: This works was reviewed by the Advarra Institutional Review Board and the Dartmouth College Committee for the Protection of Human Subjects. It was deemed exempt from IRB oversight by both committees.
: Informed consent was obtained from all individual participants included in the study.
